Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test

Peptides

Volumn 30, Issue 9, 2009, Pages 1683-1688

  Yamamoto, Tatsuo ^a   Miyazaki, Rika ^a   Yamada, Toshihiko ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Fos; GPR103; Hot plate test; Inflammtory pain; Supraspinal

Indexed keywords

ALANYLSERYLGLYCYLPROPYLLEUCYLGLYCYLTHREONYLLEUCYLALANYLGLUTAMYLGLUTAMYLLEUCYLSERYLSERYLTYROSYLSERYLARGINYLARGINYLLYSYLGLYCYLGLYCYLPHENYLALANYLSERYLPHENYLALANYLARGINYLPHENYLALANYL SULFATE; ANALGESIC AGENT; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE FF; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; P 518; PROTEIN FOS; UNCLASSIFIED DRUG;

AGITATION; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HOT PLATE TEST; INFLAMMATION; MALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-ANXIETY AGENTS; ARGININE; FORMALDEHYDE; HOT TEMPERATURE; INJECTIONS, INTRAVENTRICULAR; MALE; NARCOTIC ANTAGONISTS; NEUROPEPTIDE Y; NEUROPEPTIDES; OLIGOPEPTIDES; PAIN; PAIN MEASUREMENT; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, G-PROTEIN-COUPLED; SPINAL CORD;

RATTUS;

EID: 67849086685     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.05.027     Document Type: Article

References (17)

1. Altier N., Dray A., Menard D., and Henry J.L. Neuropeptide FF attenuates allodynia in models of chronic inflammation and neuropathy following intrathecal or intracerebroventricular administration. Eur J Pharmacol 407 (2000) 245-255
2. Bruzzone F., Lectez B., Alexandre D., Jegou S., Mounien L., Tollemer H., et al. Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat. J Comp Neurol 503 (2007) 573-591
3. Chartrel N., Dujardin C., Anouar Y., Leprince J., Decker A., Clerens S., et al. Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity. Proc Natl Acad Sci USA 100 (2003) 15247-15252
4. Fang Q., Guo J., He F., Peng Y.-I., Chang M., and Wang R. In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist. Peptide 27 (2006) 2207-2213
5. Fukusumi S., Yoshida H., Fujii R., Maruyama M., Komatsu H., Habata Y., et al. A new peptidic ligand and its receptor regulating adrenal function in rats. J Biol Chem 278 (2003) 46387-46395
6. Hammond D.L., Wang H., Nakashima N., and Basbaum A.I. Differential effects of intrathecally administered delta and mu opioid receptor agonist on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat. J Pharmacol Exp Ther 284 (1998) 378-387
7. Hunt S.P., Pini A., and Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328 (1987) 632-634
8. Jones S.L. Descending noradrenergic influences on pain. Prog Brain Res 88 (1991) 381-394
9. Mollereau C., Mazarguil H., Marcus D., Quelven I., Kotani M., Lannoy V., et al. Pharmacological characterization of human NPFF1 and NPFF2 receptors expressed in CHO cells by using NPY Y1 receptor antagonists. Eur J Pharmacol 451 (2002) 245-256
10. O'Callaghan J.P., and Holtzman S.G. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J Pharmacol Exp Ther 192 (1975) 497-505
11. Rudolf K., Eberlein W., Engel W., Wieland H.A., Willim K.D., Entzeroth M., et al. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol 271 (1994) R11-R13
12. Takayasu S., Sakurai T., Iwasaki S., Teranishi H., Yamanaka A., Williams S.C., et al. A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice. Proc Natl Acad Sci USA 103 (2006) 7438-7443
13. Thomsen M., Wortwein G., Olesen M.V., Begtrup M., Havez S., Bolwig T.G., et al. Involvement of Y5 receptors in neuropeptide Y agonist-induced analgesic-like effect in the rat hot plate test. Brain Res 1155 (2007) 49-55
14. Wheeler-Aceto H., Porreca F., and Cowan A. The rat formalin test: comparison of noxious agents. Pain 40 (1990) 229-238
15. Yamamoto T., Nozaki-Taguchi N., and Chiba T. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and the rat hot-plate test. Br J Pharmacol 137 (2002) 170-176
16. Yamamoto T., Wada T., and Miyazaki R. Analgesic effects of intrathecally administered 26RFa, an intrinsic agonist for GPR103, on formalin test and carrageenan test in rats. Neuroscience 157 (2008) 214-222
17. Yamamoto T., and Yaksh T.L. Comparison of the antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 77 (1992) 757-763